ARKG Holdings of Recursion Pharmaceuticals (RXRX) - Updated Daily
Bioinformatics
Key Statistics
Statistics
| ⚖️Weighting | 🧢Market Cap |
|---|---|
| 1.68% | $1.58b |
| 🏋🏿♂️Weight Rank In ARKG | 🌏Country |
| 23 | 🇺🇸United States |
| 🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
| 50 | $19.22 |
| 🎫ARK Ownership Percent | |
| 2.14% | |
| Description | |
|---|---|
| recursion pharmaceuticals has developed a powerful drug discovery platform involving millions of rapid, automated experiments and analysis to discover new therapeutics. our platform has resulted in the massive parallelization of drug discovery. we have deployed this platform in pursuit of drugs for the treatment of rare genetic diseases. we partner or out-license these leads to major pharmaceutical companies early in development. our horizontal business model focused on discovery accelerates our impact and reduces our costs by avoiding slow and costly in-house development, and allows us to spread risk across many new therapeutic opportunities. | |
| Website | |
| recursionpharma.com |
Other ETFs That Hold RXRX
Research Notes and Commentary for RXRX
No Research Notes Found for RXRX